Dart Biosciences

Dart Biosciences is a biotechnology company developing a platform that uses engineered immune cells as living delivery vehicles for genetic medicines.

By leveraging immune cells' natural ability to localise to disease-relevant tissues, the platform aims to achieve more spatially precise genetic payload transfer with reduced systemic exposure compared to viral vectors and lipid nanoparticles.

The modular architecture is designed to support conditional payload release and repeat administration across multiple disease areas.